Exponent (EXPO) is back in focus after its latest quarter, where revenue grew 10.5% year on year and topped forecasts by 1.8%, while earnings per share fell short and raised questions about profitability.
See our latest analysis for Exponent.
Since that earnings release, the stock’s 30 day share price return is down 16.25% and the year to date share price return is down 18.76%, while the 1 year total shareholder return has declined 26.98%. This points to fading momentum as investors reassess earnings risk.
If this kind of repricing has you looking for other ideas in the market, it can be useful to scan for companies exposed to long term themes such as AI, robotics and automation using the 32 robotics and automation stocks
With revenue still growing but the share price under pressure, and analysts’ targets sitting higher than the current US$56.99 level, the key question is whether Exponent is now undervalued or if the market is already pricing in future growth.
Most Popular Narrative: 36.7% Undervalued
With the most followed narrative putting fair value at $90 versus the current $56.99 share price, Exponent is framed as materially undervalued based on long term assumptions.
The analysts have a consensus price target of $90.0 for Exponent based on their expectations of its future earnings growth, profit margins and other risk factors. In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $694.8 million, earnings will come to $137.5 million, and it would be trading on a PE ratio of 36.5x, assuming you use a discount rate of 7.4%.
Want to see what justifies that higher earnings and margin profile, plus a richer future earnings multiple, all summarized in one valuation story? The full narrative lays out the revenue runway, profitability path, and pricing assumptions that sit behind that $90 fair value, and how they fit together over the coming years.
Result: Fair Value of $90 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the story could shift if utilization stays subdued or regulatory work remains soft. This may keep margins under pressure and challenge those higher earnings assumptions.
Find out about the key risks to this Exponent narrative.
Another View: Premium P/E Sends a Different Signal
There is a twist when you look at Exponent through its P/E. The stock trades at 25.4x earnings, compared with a fair ratio of 17.8x, the US Professional Services average of 18.9x, and a peer average of 13.4x. That kind of premium suggests valuation risk if future growth or margins fall short, so the discount to fair value may not be as straightforward as it looks.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With sentiment clearly mixed, this is a moment to move quickly and weigh the evidence yourself. Start with the balance of 5 key rewards and 1 important warning sign.
Looking for more investment ideas?
If Exponent has sharpened your focus, do not stop here. Use the Simply Wall Street screener to surface other opportunities that fit your style and risk comfort.
- Target steadier compounding by checking out companies with reliable payouts and higher yields through the 12 dividend fortresses.
- Zero in on potential value opportunities that combine quality fundamentals with attractive pricing via the 54 high quality undervalued stocks.
- Prioritise resilience by filtering for companies with stronger finances using the solid balance sheet and fundamentals stocks screener (46 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com